WHO ICTRP trial
Multi-center, randomized, double blind, active control, phase II study to…
KCT0010861 · Clinical Research Information Service (CRIS) · Not Recruiting
Key facts
| Trial ID | KCT0010861 |
|---|---|
| Public title | Multi-center, randomized, double blind, active control, phase II study to evaluate the safety and immunogenicity of BVN008 to healthy adolescent and adult volunteer aged 10 years and older |
| Scientific title | Multi-center, randomized, double blind, active control, phase II study to evaluate the safety and immunogenicity of BVN008 to healthy adolescent and adult volunteer aged 10 years and older |
| Primary sponsor | Boryungbiopharma |
| Registry | Clinical Research Information Service (CRIS) |
| Recruitment status | Not Recruiting |
| Study type | Interventional Study |
| Phase | Phase2 |
| Countries | Korea, Republic of |
| Conditions | Factors influencing health status and contact with health services |
| Interventions | Biological/Vaccine, Non-Stem Cell : 1. Test Vaccine: BVN008 (adsorbed diphtheria, tetanus, and purified pertussis combination vaccine for adults) in two doses (each for Test group 1 and Test group 2) [Boryung Biopharma Co. Ltd.] - Test… |
| Registration date | Aug 7, 2025 |
| Target size | 270 |
| Registry page | cris.nih.go.kr |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: